|
1
|
Okada S, Goto H and Yotsumoto M: Current
status of treatment for primary effusion lymphoma. Intractable Rare
Dis Res. 3:65–74. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Nador RG, Cesarman E, Chadburn A, Dawson
DB, Ansari MQ, Sald J and Knowles DM: Primary effusion lymphoma: A
distinct clinicopathologic entity associated with the Kaposi's
sarcoma-associated herpes virus. Blood. 88:645–656. 1996.PubMed/NCBI
|
|
3
|
Chen YB, Rahemtullah A and Hochberg E:
Primary effusion lymphoma. Oncologist. 12:569–576. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Carbone A and Gloghini A:
KSHV/HHV8-associated lymphomas. Br J Haematol. 140:13–24.
2008.PubMed/NCBI
|
|
5
|
Keller SA, Schattner EJ and Cesarman E:
Inhibition of NF-kappaB induces apoptosis of KSHV-infected primary
effusion lymphoma cells. Blood. 96:2537–2542. 2000.PubMed/NCBI
|
|
6
|
Gopalakrishnan R, Matta H and Chaudhary
PM: A purine scaffold HSP90 inhibitor BIIB021 has selective
activity against KSHV-associated primary effusion lymphoma and
blocks vFLIP K13-induced NF-κB. Clin Cancer Res. 19:5016–5026.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Cannon ML and Cesarman E: The KSHV G
protein-coupled receptor signals via multiple pathways to induce
transcription factor activation in primary effusion lymphoma cells.
Oncogene. 23:514–523. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
An J, Sun Y, Sun R and Rettig MB: Kaposi's
sarcoma-associated herpesvirus encoded vFLIP induces cellular IL-6
expression: The role of the NF-kappaB and JNK/AP1 pathways.
Oncogene. 22:3371–3385. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kwak J-Y: Fucoidan as a marine anticancer
agent in preclinical development. Mar Drugs. 12:851–870. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang W, Wang S-X and Guan H-S: The
antiviral activities and mechanisms of marine polysaccharides: An
overview. Mar Drugs. 10:2795–2816. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Mori N, Nakasone K, Tomimori K and
Ishikawa C: Beneficial effects of fucoidan in patients with chronic
hepatitis C virus infection. World J Gastroenterol. 18:2225–2230.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Araya N, Takahashi K, Sato T, Nakamura T,
Sawa C, Hasegawa D, Ando H, Aratani S, Yagishita N, Fujii R, et al:
Fucoidan therapy decreases the proviral load in patients with human
T-lymphotropic virus type-1-associated neurological disease.
Antivir Ther. 16:89–98. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Takeda K, Tomimori K, Kimura R, Ishikawa
C, Nowling TK and Mori N: Anti-tumor activity of fucoidan is
mediated by nitric oxide released from macrophages. Int J Oncol.
40:251–260. 2012.PubMed/NCBI
|
|
14
|
Kimura R, Rokkaku T, Takeda S, Senba M and
Mori N: Cytotoxic effects of fucoidan nanoparticles against
osteosarcoma. Mar Drugs. 11:4267–4278. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Renne R, Zhong W, Herndier B, McGrath M,
Abbey N, Kedes D and Ganem D: Lytic growth of Kaposi's
sarcoma-associated herpesvirus (human herpesvirus 8) in culture.
Nat Med. 2:342–346. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Katano H, Hoshino Y, Morishita Y, Nakamura
T, Satoh H, Iwamoto A, Herndier B and Mori S: Establishing and
characterizing a CD30-positive cell line harboring HHV-8 from a
primary effusion lymphoma. J Med Virol. 58:394–401. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Mori N and Prager D: Transactivation of
the interleukin-1alpha promoter by human T-cell leukemia virus type
I and type II Tax proteins. Blood. 87:3410–3417. 1996.PubMed/NCBI
|
|
18
|
Zhang C, Ao Z, Seth A and Schlossman SF: A
mitochondrial membrane protein defined by a novel monoclonal
antibody is preferentially detected in apoptotic cells. J Immunol.
157:3980–3987. 1996.PubMed/NCBI
|
|
19
|
Khan N, Afaq F and Mukhtar H: Apoptosis by
dietary factors: The suicide solution for delaying cancer growth.
Carcinogenesis. 28:233–239. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hayden MS and Ghosh S: Shared principles
in NF-kappaB signaling. Cell. 132:344–362. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Simons-Evelyn M, Bailey-Dell K, Toretsky
JA, Ross DD, Fenton R, Kalvakolanu D and Rapoport AP: PBK/TOPK is a
novel mitotic kinase which is upregulated in Burkitt's lymphoma and
other highly proliferative malignant cells. Blood Cells Mol Dis.
27:825–829. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Abe Y, Takeuchi T, Kagawa-Miki L, Ueda N,
Shigemoto K, Yasukawa M and Kito K: A mitotic kinase TOPK enhances
Cdk1/cyclin B1-dependent phosphorylation of PRC1 and promotes
cytokinesis. J Mol Biol. 370:231–245. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Vishchuk OS, Sun H, Wang Z, Ermakova SP,
Xiao J, Lu T, Xue P, Zvyagintseva TN, Xiong H, Shao C, et al:
PDZ-binding kinase/T-LAK cell-originated protein kinase is a target
of the fucoidan from brown alga Fucus evanescens in the prevention
of EGF-induced neoplastic cell transformation and colon cancer
growth. Oncotarget. 7:18763–18773. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Park J-H, Yoon D-S, Choi H-J, Hahm D-H and
Oh S-M: Phosphorylation of IκBα at serine 32 by
T-lymphokine-activated killer cell-originated protein kinase is
essential for chemoresistance against doxorubicin in cervical
cancer cells. J Biol Chem. 288:3585–3593. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Michai M, Goto H, Hattori S,
Vaeteewoottacharn K, Wongkham C, Wongkham S and Okada S: Soluble
CD30: A possible serum tumor marker for primary effusion lymphoma.
Asian Pac J Cancer Prev. 13:4939–4941. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yang C, Chung D, Shin IS, Lee H, Kim J,
Lee Y and You S: Effects of molecular weight and hydrolysis
conditions on anticancer activity of fucoidans from sporophyll of
Undaria pinnatifida. Int J Biol Macromol. 43:433–437. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Azuma K, Ishihara T, Nakamoto H, Amaha T,
Osaki T, Tsuka T, Imagawa T, Minami S, Takashima O, Ifuku S, et al:
Effects of oral administration of fucoidan extracted from
Cladosiphon okamuranus on tumor growth and survival time in a
tumor-bearing mouse model. Mar Drugs. 10:2337–2348. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Jiao G, Yu G, Zhang J and Ewart HS:
Chemical structures and bioactivities of sulfated polysaccharides
from marine algae. Mar Drugs. 9:196–223. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Haneji K, Matsuda T, Tomita M, Kawakami H,
Ohshiro K, Uchihara JN, Masuda M, Takasu N, Tanaka Y, Ohta T, et
al: Fucoidan extracted from Cladosiphon okamuranus Tokida induces
apoptosis of human T-cell leukemia virus type 1-infected T-cell
lines and primary adult T-cell leukemia cells. Nutr Cancer.
52:189–201. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Pahl HL: Activators and target genes of
Rel/NF-kappaB transcription factors. Oncogene. 18:6853–6866. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Iwanaga R, Ohtani K, Hayashi T and
Nakamura M: Molecular mechanism of cell cycle progression induced
by the oncogene product Tax of human T-cell leukemia virus type I.
Oncogene. 20:2055–2067. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Brown RT, Ades IZ and Nordan RP: An acute
phase response factor/NF-kappa B site downstream of the junB gene
that mediates responsiveness to interleukin-6 in a murine
plasmacytoma. J Biol Chem. 270:31129–31135. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Li N, Zhang Q and Song J: Toxicological
evaluation of fucoidan extracted from Laminaria japonica in Wistar
rats. Food Chem Toxicol. 43:421–426. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Chung H-J, Jeun J, Houng S-J, Jun H-J,
Kweon D-K and Lee S-J: Toxicological evaluation of fucoidan from
Undaria pinnatifida in vitro and in vivo. Phytother Res.
24:1078–1083. 2010.PubMed/NCBI
|
|
35
|
Shimizu J, Wada-Funada U, Mano H, Matahira
Y, Kawaguchi M and Wada M: Proportion of murine cytotoxic T cells
is increased by high molecular-weight fucoidan extracted from
Okinawa Mozuku (Cladosiphon okamuranus). J Health Sci. 51:394–397.
2005. View Article : Google Scholar
|
|
36
|
Bosma GC, Custer RP and Bosma MJ: A severe
combined immunodeficiency mutation in the mouse. Nature.
301:527–530. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Dewan MZ, Terunuma H, Toi M, Tanaka Y,
Katano H, Deng X, Abe H, Nakasone T, Mori N, Sata T, et al:
Potential role of natural killer cells in controlling growth and
infiltration of AIDS-associated primary effusion lymphoma cells.
Cancer Sci. 97:1381–1387. 2006. View Article : Google Scholar : PubMed/NCBI
|
